4.7 Article

miR-1307 promotes hepatocarcinogenesis by CALR-OSTC-endoplasmic reticulum protein folding pathway

期刊

ISCIENCE
卷 24, 期 11, 页码 -

出版社

CELL PRESS
DOI: 10.1016/j.isci.2021.103271

关键词

-

资金

  1. National Natural Science Foundation of China (NCSF) [81773158, 82073130]
  2. Science and Technology Commission of Shanghai Municipality Shanghai Science and Technology Plan Basic Research Field Project [19JC1415200]
  3. Science and Tech-nology Commission of Shanghai Municipality Shanghai Science and Technology Plan Basic Research Field Project [20JC1411400]

向作者/读者索取更多资源

miR-1307 is highly expressed in liver cancer and promotes hepatocarcinogenesis by inhibiting methyltransferase proteins, increasing histone methylation modifications, and affecting cell cycle protein binding abilities.
miR-1307 is highly expressed in liver cancer and inhibits methyltransferase protein8. Thereby, miR 1307 inhibits the expression of KDM3A and KDRI3B and increases the methylation modification of histone H3 lysine 9, which enhances the expression of endoplasmic-reticulum-related gene CALR. Of note, miR-1307 weakens the binding ability of OSTC to CDK2, CDK4, CyclinD1, and cydinE and enhances the binding ability of CALR to CDK2, CDK4, CyclinD1, and cyclinE, decreasing of p21WAF1/CIP1, GADD45, pRB, and p18, and decreasing of ppRB. Furthermore, miR-1307 increases the activity of H-Ras, PKM2, and PLK1. Strikingly, miR-1307 reduces the binding ability of OSTC to ATG4 and enhances the binding ability of CALR to ATG4. Therefore, miR-1307 reduces the occurrence of autophagy based on ATG4-LC3-ATG3-ATG7-ATG5-ATG16L1-ATG12-ATG9-Beclin1. In particular, miR-1307 enhances the expression of PAK2, PLK1, PRKAR2A, MYBL1, and Trim44 and inhibits the expression of Sash1 and Smad5 via autophagy. Our observations suggest that miR-1307 promotes hepatocarcinogenesis by CALR-OSTC-endoplasmic reticulum protein folding pathway.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据